Auven Therapeutics Management LLLP-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Auven Therapeutics Management LLLP - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013106
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Auven Therapeutics Management LLLP (Auven Therapeutics Management), formerly Celtic Therapeutics Management LLLP is a private equity firm that provides life science investment strategy. The firm invests in therapeutic products or platforms. It has invested in diversified portfolio of biologic and small molecule therapeutic candidates for therapeutic indications. Auven Therapeutics Management’s investment portfolio includes ADC Therapeutics, Spirogen, Kolltan Pharmaceuticals and Sprout Pharmaceuticals. The firm also offers business development stratergy to acquire controlling ownership on therapeutic products. It operates in St. Thomas and Ft. Lauderdale, the US. Auven Therapeutics Management is headquartered in St. Thomas, Virgin islands, the US.

Auven Therapeutics Management LLLP – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
ADC Therapeutics To Raise US$50 Million In Venture Financing 10
Private Equity 12
ADC Therapeutics Raises USD200 Million in Private Placement of Shares 12
Licensing Agreements 13
Auven Therapeutics Enters Into Licensing Agreement With Icahn School Of Medicine At Mount Sinai For Kiacta 13
Celtic Therapeutics Enters Into Licensing Agreement With Resolvyx Pharma For RX-10045 14
Equity Offering 16
ADC Therapeutics Raises USD105 Million in Private Placement of Shares 16
ADC Therapeutics Raises USD80 Million in Private Placement of Shares 17
Acquisition 18
Sun Pharma Acquires Ocular Technologies from Auven Therapeutics 18
MedImmune Acquires Spirogen From Auven Therapeutics For US$440 Million 19
Auven Therapeutics Management LLLP – Key Competitors 21
Auven Therapeutics Management LLLP – Key Employees 22
Auven Therapeutics Management LLLP – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Key Facts 2
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Auven Therapeutics Management LLLP, Deals By Therapy Area, 2011 to YTD 2017 8
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
ADC Therapeutics To Raise US$50 Million In Venture Financing 10
ADC Therapeutics Raises USD200 Million in Private Placement of Shares 12
Auven Therapeutics Enters Into Licensing Agreement With Icahn School Of Medicine At Mount Sinai For Kiacta 13
Celtic Therapeutics Enters Into Licensing Agreement With Resolvyx Pharma For RX-10045 14
ADC Therapeutics Raises USD105 Million in Private Placement of Shares 16
ADC Therapeutics Raises USD80 Million in Private Placement of Shares 17
Sun Pharma Acquires Ocular Technologies from Auven Therapeutics 18
MedImmune Acquires Spirogen From Auven Therapeutics For US$440 Million 19
Auven Therapeutics Management LLLP, Key Competitors 21
Auven Therapeutics Management LLLP, Key Employees 22
Auven Therapeutics Management LLLP, Other Locations 23
Auven Therapeutics Management LLLP, Subsidiaries 23

★海外企業調査レポート[Auven Therapeutics Management LLLP-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rocky Mountain Chocolate Factory, Inc.:企業の戦略・SWOT・財務分析
    Rocky Mountain Chocolate Factory, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rocky Mountain Chocolate Factory, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Endo International Plc (ENDP):企業の財務・戦略的SWOT分析
    Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Cimarex Energy Co (XEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Cimarex Energy Co (Cimarax) is an independent upstream oil and natural gas company. It carries out the exploration and production of crude oil, natural gas and natural gas liquids (NGLs). The company’s operations are concentrated in two main areas namely the Mid-Continent region consisting o …
  • Mineral Resources Ltd
    Mineral Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Mineral Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • GlaxoSmithKline Plc (GSK):医療機器:M&Aディール及び事業提携情報
    Summary GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV, respiratory, cancer, immuno-inflammation, anti-virals, central nervo …
  • TE Connectivity Ltd (TEL):企業の財務・戦略的SWOT分析
    TE Connectivity Ltd (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PT. Millennium Pharmacon International TBK (SDPC):企業の財務・戦略的SWOT分析
    PT. Millennium Pharmacon International TBK (SDPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Prairie Land Electric Cooperative, Inc.:発電所・企業SWOT分析
    Prairie Land Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informat …
  • Jinchuan Group International Resources Co. Ltd:企業の戦略・SWOT・財務情報
    Jinchuan Group International Resources Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary Jinchuan Group International Resources Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Newalta Corporation (NAL):石油・ガス:M&Aディール及び事業提携情報
    Summary Newalta Corp (Newalta) is a provider of sustainability-enhancing solutions to the oil and gas industry. It adopts technologies to maximize the value inherent in oil and gas exploration and production waste streams. The company provides engineered environmental solutions for waste management …
  • Airgain, Inc. (AIRG):企業の財務・戦略的SWOT分析
    Airgain, Inc. (AIRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hersha Hospitality Trust:企業のM&A・事業提携・投資動向
    Hersha Hospitality Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hersha Hospitality Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Bharat Dynamics Limited:企業の戦略・SWOT・財務情報
    Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Babcock Power Inc:企業の戦略的SWOT分析
    Babcock Power Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Northern Trust Corporation:企業のM&A・事業提携・投資動向
    Northern Trust Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Northern Trust Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Bicycle Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Bicycle Therapeutics Ltd (Bicycle Therapeutics) is a biotechnology company that develops bicyclic peptides Medicines for the treatment of cancers and other debilitating diseases. The company's proprietary bicyclic peptide technology enables systematic cyclisation of peptides and helps to ide …
  • Turquoise Hill Resources Ltd:企業の戦略・SWOT・財務情報
    Turquoise Hill Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Turquoise Hill Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Stilo International Plc (STL):企業の財務・戦略的SWOT分析
    Summary Stilo International Plc (Stilo) is a technology company that offers cloud content solutions. The company’s products include developer tools, XML cloud conversion and SME authoring. It offers digital content and publishes information to multiple channels such as print, web, CD-ROM, smartphone …
  • Scandinavian Biopharma Holding AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Scandinavian Biopharma Holding AB (Scandinavian) is a biotechnology company that distributes vaccines and immunoglobulin. The company offers diagnostics, vaccines, dental and immunoglobulin products. Its products are used in the therapeutic areas of diphtheria and tetanus, tuberculosis, poli …
  • Johnson Matthey PLC:戦略・SWOT・企業財務分析
    Johnson Matthey PLC - Strategy, SWOT and Corporate Finance Report Summary Johnson Matthey PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆